Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 19, 2023

SELL
$18.66 - $38.58 $5,821 - $12,036
-312 Reduced 2.44%
12,491 $480,000
Q1 2023

May 12, 2023

BUY
$21.53 - $26.8 $14,252 - $17,741
662 Added 5.45%
12,803 $296,000
Q4 2022

Feb 10, 2023

SELL
$18.63 - $27.35 $17,176 - $25,216
-922 Reduced 7.06%
12,141 $318,000
Q3 2022

Nov 03, 2022

BUY
$17.51 - $23.37 $228,733 - $305,282
13,063 New
13,063 $257,000

Others Institutions Holding KDNY

About CHINOOK THERAPEUTICS, INC.


  • Ticker KDNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,896,300
  • Description
  • Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...
More about KDNY
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.